The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. While the immune system usually clears HPV infections, ...

The study discovered that previously unidentified HPV and human DNA enhancers increased the expression of tumor-promoting genes in cancer cells, leading to the production of more of the virus and ...

Scientists say there is a powerful opportunity to save lives because nearly 40% of cancers are preventable.

During carcinogenesis, the HPV genome integrates into the host genome, often disrupting the E2 gene, which normally suppresses E6 and E7 expression. HPV integration can occur randomly in the host ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) that causes it was safe and yielded complete response in many cases, a small ...

New research reveals that triggering a cell’s DNA damage response could be a promising avenue for developing novel treatments against several rare but devastating viruses for which no antiviral ...

By: Dr Sampada Dessai A mother's health plays an important role in the family. It is she who takes care of all others in the ...

The HPV vaccine is reshaping cervical cancer prevention by blocking high-risk HPV infections early, offering long-lasting ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study shows nearly 1 in 3 men has at least one type of HPV. Why aren't men screened for the virus as often as women? (Photo ...